BioSpace News Archive

BioClin Therapeutics, Inc., a clinical stage drug development company announced today that data will be presented from its ongoing Phase 1b/2 study of B-701, a first-in-class anti-fibroblast growth factor receptor 3 (FGFR3) monoclonal antibody, plus docetaxel for metastatic bladder cancer at a poster session at the 2018 American Society for Clinical Oncology (ASCO) meeting being held June 1-5, 2018 in Chicago, IL.

FDA’s highest priorities is advancing policies that increase competition as a way to help make drugs more affordable and improve access.

Lonza is hosting a free 60-minute webinar on the CRISPR/Cas9 genome editing method.

Ra Pharmaceuticals, Inc. (NASDAQ:RARX) today announced that data from the Company’s oral, small molecule, complement C5 inhibitor program and data from the Company’s global, Phase 2 clinical program evaluating RA101495 SC for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) will be presented at the 23rd Congress of the European Hematology Association (EHA) from June 14-17, 2018 in Stockholm, Sweden.

X4 Pharmaceuticals will present clinical data highlighting their Phase II X4P-001-RD drug.

Protalex, Inc. (OTCQB: PRTX), a clinical-stage biopharmaceutical company, today announced that preliminary results from its European Phase 1b open-label, dose-escalation study of PRTX-100 in adult patients with persistent/chronic immune thrombocytopenia (ITP) (PRTX-100-203 Study) will be presented at the upcoming European Hematology Association (EHA) 23rd Annual Meeting being held in Stockholm from June 14-17, 2018

ConnectiveRx, a market-leader in patient and provider engagement services with hub, adherence and market access solutions for specialty and branded medications today announced the acquisition of The Macaluso Group (TMG), a technology-driven provider of specialty pharmacy benefits.

U.S. Food and Drug Administration sent official requests for information to four e-cigarette manufacturers.

Olympus Corporation of the Americas provides equipment for the CHEST Innovation, Simulation, and Training Center with its charitable contribution

Pharmacy benefit manager’s enhanced program helps payers safely address members’ pain and lower risk of abuse Program helps educate and guide patients prescribed opioids to safely use these powerful drugs